Federated Hermes, Inc. Durect Corp Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $67,211 - $84,854	-42,007 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.86 - $2.87 $43,070 - $66,457	23,156 Added 122.84%	42,007 $83,000
Q4 2020 Feb 12, 2021	BUY	$1.65 - $2.43 $876 - $1,290	531 Added 2.9%	18,851 $39,000
Q3 2020 Nov 12, 2020	BUY	$1.6 - $2.35 $29,312 - $43,052	18,320 New	18,320 $31,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.